Data / Form D filings / Vigil Neuroscience, Inc.
Vigil Neuroscience, Inc.: Form D filings
Vigil Neuroscience, Inc., a pharmaceuticals company in Cambridge, MA, filed 4 Form D notices with the SEC between 2020 and 2022. The latest, on August 29, 2022, reports $75 million sold of a $75 million offering to 9 investors.
Find out what Vigil Neuroscience, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1 BROADWAY, 7TH FLOOR, SUITE 07-300, Cambridge, MA, 02142
- Phone
- (857) 254-4445
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1827087
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 29, 2022 | New notice | $74,999,705 | $74,999,705 | $0 | 9 | Aug 16, 2022 | sec.gov |
| Aug 25, 2021 | New notice | $89,999,961 | $89,999,961 | $0 | 19 | Aug 13, 2021 | sec.gov |
| Jun 15, 2021 | Amendment | $49,999,989 | $49,999,989 | $0 | 6 | Sep 18, 2020 | sec.gov |
| Oct 5, 2020 | New notice | $49,999,989 | $29,999,995 | $19,999,994 | 6 | Sep 18, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bruce Booth | Director | |
| Ivana Magovcevic-Liebisch | Executive Officer, Director | |
| Christopher Verni | Executive Officer | |
| Mary Thistle | Director | |
| Stefan Vitorovic | Director | |
| Evan Thackaberry | Executive Officer | |
| Cheryl Blanchard | Director | |
| Suzanne Bruhn | Director | |
| Gerhard Koenig | Director | |
| Spyros Papapetropoulos | Executive Officer | |
| Jennifer Ziolkowski | Executive Officer | |
| Shaan Gandhi | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Aug 29, 2022 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Vigil Neuroscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.